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 ​Abstract 
 
The various cells that support neurons in both the central and peripheral nervous 
systems are known collectively as neuroglia, or glia. Astrocytes, a type of glial cell found 
exclusively in the central nervous system (i.e. the brain and spinal cord), are particularly 
abundant and serve many functions. One of the most important is the role these cells play in 
the brain as a defense against harmful substances, many of which can be found in the 
environment and make their way into the human body as xenobiotic substances. Elemental 
arsenic in its inorganic form occurs naturally throughout the Earth’s crust, but poses a major 
health risk worldwide when it is found at elevated levels particularly in groundwater used as 
a source for domestic or agricultural use. Exposure to arsenic has been shown to cause a 
number of adverse health effects, from cardiovascular and liver damage to neurological 
dysfunction, though much less is known about its effects in the brain. Astrocytes are likely to 
play a protective role in the form of a barrier capable of detoxifying inorganic arsenic 
molecules carried to the brain via the circulatory system. However, the mechanism(s) by 
which the process of detoxification occurs has yet to be fully elucidated. Using primary 
astrocyte cultures, the present study focused on the role of glutathione, glucose metabolism, 
and mitochondria in minimizing the adverse neurological effects of xenobiotic arsenic in 
astrocytes. Results show that the introduction of arsenic compounds to cultures of astrocytes 
stimulates changes in intracellular glucose metabolism, altering flux of glucose-derived 
carbons through the glycolytic and oxidative pathways. The diversion has been indicated to 
result in an increased anaplerotic synthesis of glutathione, an important intracellular 
tripeptide for xenobiotic defense. In addition, results suggest that mitochondria rely on the 
input of acetyl-CoA, which, surprisingly, alludes to the importance of fatty acid metabolism 
1 
as the alternate carbon source for acetyl-CoA in the mitochondrial contribution to 
detoxification of arsenic via glutathione synthesis. 
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Introduction 
 
Astrocytes as primary defense against xenobiotics 
 
Glial astrocytes in the central nervous system (CNS) play a crucial role, performing a 
variety of functions in support of neurons. Astrocytes help to facilitate a stable intracellular 
and extracellular environment by maintaining redox status via glutathione (GSH) synthesis, 
balance energy metabolism via glycolytic and mitochondrial activity, and function in 
neuronal signaling pathways via production, release, and reuptake of neurotransmitter 
molecules (1). Ultimately, these dynamic cells constitute the primary defense against 
xenobiotic threat in the form of a protective layer of cells known as the blood-brain barrier, 
which serves to screen the blood before it reaches highly sensitive neurons. Cellular 
processes extending from the cell bodies of astrocytes wrap around capillaries and arterioles 
transporting blood carrying nutrients, drugs, and potentially harmful xenobiotic substances 
from the circulatory system into the CNS. These processes form a virtually continuous layer 
between the bloodstream and the brain that allows astrocytes, functioning as intermediaries, 
to take up and metabolize blood contents (5). In the case of harmful xenobiotics, this action 
helps to reduce the negative impact on neural function through metabolic detoxification. 
 
Astrocytes and glutathione 
GSH, a tripeptide ubiquitous in the body’s cells, is most commonly identified in an 
antioxidant capacity as an important reducing agent under conditions of oxidative stress. It 
undergoes an oxidation-reduction cycle, in which GSH is oxidized to glutathione disulfide 
(GSSG). In astrocytes, it is also exported via multidrug resistance-associated protein 1 
(MRP1) for subsequent cleavage and uptake by neurons as cysteine, a precursor which is then 
resynthesized to glutathione. Its role in xenobiotic detoxification in astrocytes, however, is 
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less understood. It has been shown in previous studies that biotransformation occurs via 
glutathione-S-transferase enzymes to convert arsenic taken up by astrocytes into various 
metabolites (3). Another mechanism that has been suggested is the formation of complexes 
with inorganic arsenic, thus rendering them less toxic, though this ability as well as the ability 
to then export the complexed GS-As adducts via MRP1 have yet to be confirmed in 
astrocytes (3). 
 
Glucose metabolism in astrocytes 
Most cells in the body, especially in the brain, rely on glucose metabolism for energy 
production and survival. Astrocytes, too, rely on these pathways; this is due to the fact that 
glucose readily crosses the blood-brain barrier, and is normally present in stable 
concentrations in circulation (4). The major pathways of glucose metabolism are glycolysis 
and oxidative phosphorylation. In astrocytes these pathways have been shown to be 
compartmentalized in distinct regions in the cell: oxidative metabolism, carried out by 
mitochondria, takes place in the cell body, while glycolysis is carried out in the cellular 
processes due to the inability to house mitochondria, which are approximately twice the 
diameter of the processes themselves (4). Oxidative phosphorylation is the primary source of 
adenosine triphosphate (ATP), the main energy molecule of cellular metabolism, with a much 
larger net yield (32 ATP) compared to glycolysis (2 ATP), yet the cell bodies of astrocytes 
comprise only 2% of their volume (4). In conditions of xenobiotic stress, astrocytes increase 
glucose flux through both of these pathways (4), though to what extent and for what reason 
each is involved in the process of detoxifying arsenic is has not been extensively shown in 
astrocytes. 
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Arsenic 
Arsenic poses a pervasive health risk around the world, contributing to a number of 
high-priority and potentially fatal diseases, including cardiovascular disease and cancer, and 
has more recently been implicated as a risk factor of neurological disorders.  It is found 
throughout the Earth’s crust primarily as a natural geologic component, as well as as a result 
of anthropogenic activity. Most significantly, however, arsenic is found in groundwater, with 
concentrations at their highest and most catastrophic levels particularly in the regions of 
Southeast Asia, India, and China (5). In the US, groundwater contamination from arsenic is 
particularly prominent in the west and central regions, where it can be detected at levels 
meeting or exceeding the maximal safe permissible level of 10 ug/L established by the World 
Health Organization in 2011(6). The most common forms of inorganic arsenic detected in 
groundwater are the pentavalent [arsenate, As(V)] and in reduced environments, trivalent 
[arsenite, As(III)] species (7). These species are represented by sodium arsenate (NaAsO​2​) 
and arsenic trioxide (As​2​O​3​), respectively. 
Inorganic arsenic compounds are toxic to humans and animals due to their ability to 
disrupt the normal function of metabolic processes and a great number of enzymes (8). 
Historically, anthropogenic use of arsenic compounds has ranged from cosmetics to the 
production of chemical pesticides and herbicides. Exposure through these sources can result 
in acute toxicity, though in coming to understand the many adverse health effects of arsenic 
its use in such activities has largely been discontinued, whereas chronic exposure to arsenic 
as a result of groundwater contamination continues to pose substantial risk (8). Adverse 
effects of chronic arsenic exposure include increased risk of multiple types of cancer, 
diabetes, and blackfoot disease. Neurological conditions include impaired cognitive 
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development and neuropathy (8), though the etiology on a cellular level are as yet largely 
unexplored. 
Prior Research in the Franco Lab 
 
The direction of the current study was guided in part by findings previously achieved 
in the Franco lab, which served as the basis for investigation of the role of mitochondrial 
glucose metabolism and GSH in detoxification of harmful xenobiotics in astrocytes. 
 
A. Increase in glutathione prior to cell death 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Increase in intracellular glutathione content in astrocytes prior to cell death. Cells treated with NaAsO​2​ and As​2​O​3​ at 0, 2, 5, 10, 20, 
50, and 100 μM for 48h. Cells were harvested and analyzed as indicated in Methods and Materials. Astrocytes exhibit increased GSH 
content at sub-lethal levels of arsenic, shown as a result of flow cytometry (A) and in statistical analysis of these sub-lethal concentrations 
(B). ​*​ ​p < 0.05 
 
Astrocytes were treated with increasing concentrations of NaAsO​2​ and As​2​O​3​ in order 
to investigate conditions of arsenic exposure that lead to an increase in intracellular GSH 
content. It was found that at sub-lethal concentrations of each of the arsenic treatments (2 μM 
for As​2​O​3​ and 5 μM for NaAsO​2​; Figures 1A and B), GSH content increased approximately 
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1.6-fold. At greater concentrations, cell membranes were compromised and levels of cell 
viability decreased. This demonstrated that just prior to cell death, intracellular GSH 
production was likely being upregulated. 
 
 
B. Arsenic treatment results in a reduced intracellular environment 
 
 
 
 
 
 
 
 
 
 
Figure 2. Treatment with inorganic arsenic compounds causes a reduced intracellular environment in astrocytes. Cells were treated with 
concentrations of 0, 5, 10, 15, and 20 μM for 48h and analyzed as described previously (10). At concentrations of 5 μM for As​2​O​3​ and 10 
μM for NaAsO​2​, the intracellular redox status showed a reduced environment (A and B). 
 
Upon treatment with increasing concentrations of As​2​O​3​ and NaAsO​2​, analysis of 
oxidation-reduction (redox) status showed the resulting intracellular environments in both the 
cytoplasm and mitochondria (Figures 2A and B, respectively) to be reduced, again reaching 
maxima at similar respective sub-lethal concentrations. This indicates the presence of a 
higher concentration of the reduced form of glutathione, GSH, versus to its oxidized form, 
GSSG, and suggests the role of GSH in detoxification to involve a metabolic pathway other 
than redox cycling as this would instead deplete GSH content as it is converted to GSSG.  
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C. Glutathione synthesis via cytosolic and mitochondrial glucose metabolism 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rose, J., et al. (9) 
Figure 3. Glutathione is synthesized via both glycolytic and oxidative metabolism. Cells were incubated in media containing labeled 
13C-glucose. After 48h, cells were harvested and analyzed using NMR spectroscopy. Glycine and cysteine from glycolysis and glutamate 
from oxidative phosphorylation were utilized in the synthesis of GSH. (A) Following treatment with arsenic, separate cell cultures exhibited 
increased intracellular GSH content (B). ​*​ ​p < 0.05  
 
Metabolomic analysis by nuclear magnetic resonance (NMR) spectroscopy allowed 
investigators to track the pathways into which extracellular glucose was incorporated in 
astrocytes (Figure 3A). Cells were treated with labeled 13C-glucose in culture media, which 
was then taken up and metabolized, where metabolic substrates and products containing the 
labeled isotope could be identified. The results of the NMR analysis revealed that astrocytes 
rely both on glycolysis in the cytoplasm and oxidative phosphorylation in the mitochondria to 
synthesize glutathione. It was shown that cataplurotic glutamate exported from mitochondria 
was combined with glycine and cysteine (from glycolysis), highlighting the importance of 
mitochondrial activity in the biosynthesis of GSH from glucose. NMR analysis also indicated 
the same increase in GSH content following sub-lethal treatment at 5 μM NaAsO​2​ that signals 
a potential upregulation of GSH synthesis as astrocytes undergo xenobiotic threat (Figure 
3B). 
Hypothesis 
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In light of these previous results, the need for further study into the role of GSH 
synthesis via mitochondrial glucose metabolism, as well as the mechanism and significance 
of the role of GSH in the detoxification of xenobiotics, is addressed in the present study. It is 
hypothesized that i) the upregulation of glutathione in the intracellular environment is the 
result of increased biosynthesis, involving increased mitochondrial activity, and ii) that the 
resulting GSH is then directly complexed with the toxic xenobiotic compound for export 
from the cell. Furthermore, in the previous findings it was observed that both arsenic 
compounds (i.e. As​2​O​3​ and NaAsO​2​) generated similar toxic effects, though higher 
concentrations of NaAsO​2​ were required to achieve the same response (Figures 1A and B, 2A 
and B). Due to ease of acquisition and handling safety it was elected to perform further 
experiments using NaAsO​2​ only, adjusting concentrations accordingly. 
 
Methods and Materials 
 
Astrocyte cell culture 
Primary rat astrocytes were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM)/Ham’s F-12 Nutrient Mixture (GIBCO or Hyclone) supplemented with 10% fetal 
bovine serum (FBS, ​Atlanta Biologicals​), 2 mM L-glutamine (Hyclone), 1% 
streptomycin/penicillin (Hyclone) at 37°C under 5% atmospheric CO​2​. Cells were cultured in 
12-well culture plates for 48 hours, at the end of which they reached monolayer confluency, 
verified by microscope. Cells were treated as indicated in the figures. Control conditions 
included the appropriate vehicle. Treatments started with fresh media. 
 
 
 
Cell viability determination 
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Loss of cell viability was determined using flow cytometry (FACS, Fluorescence 
Activated Cell Sorting) by measuring propidium iodide (PI, 1 µg/ml, ​Life Technologies or 
Sigma-Aldrich​) and monochlorobimane (mBCl, M) as markers for plasma membrane 
integrity loss. PI was detected using BluFl3 or BluFl5 and mBCL was detected using VioFl2 
in a BDFACSort (Cytek-DxP-10 upgrade). Data were analyzed using FlowJo 7.6.5 software. 
Total cell count set to 10,000. At least 4 experimental replicates were performed. 
 
Statistical analysis 
Collected data were analyzed according to statistical criteria by using paired or 
unpaired t-test, two-way ANOVA, and the appropriate parametric or non-parametric 
normality post-test using SIGMA-PLOT/STAT package. A probability value of p<0.05 was 
considered as statistically significant. Data were plotted as mean values of at least 4 
experimental replicates ± standard error of the mean (SE) using the same statistical package 
for data analysis. Flow cytometry graphs presented are representative of at least 4 
experimental replicates. 
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Results and Discussion 
 
A. Blocking glutathione synthesis potentiates cell death 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Inhibition of GSH synthesis results in cell death. Astrocytes treated as indicated in figures for 48h. Cells experience complete loss 
in viability after treatment with 500 μM BSO and 10 μM NaAsO​2​ (A) compared to modest decrease in viability with 300 μM H​2​O​2​. Cells 
treated with 6AN were not affected in the presence of NaAsO​2​ (C) compared to decreased viability with 300 μM H​2​O​2​. ​*​ ​p < 0.05 
 
In order to investigate whether it is the biosynthesis of glutathione, rather than redox 
cycling, that is most significantly responsible in the detoxification of arsenic, primary 
astrocyte cultures were treated with 0 μM, 10 μM, and 20 μM of NaAsO​2​ and separately with 
0 μM and 300 μM hydrogen peroxide (H​2​O​2​, an agent of oxidative stress that induces redox 
cycling), both with or without buthionine sulfoximine (BSO, 500 μM), an inhibitor of 
glutathione synthesis (Figures 4A and B; see Figure 10, Appendix for inhibitor action 
diagram and list of compounds used) . Cultures were collected and analyzed as indicated in 
Methods and Materials. Treatment with arsenic in the presence of BSO resulted in a complete 
loss of cell viability, compared to the reduction in viability following treatment with H​2​O​2​. 
Therefore, while oxidative stress may have a moderate effect when cells are treated with a 
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known oxidizer, the comparatively greater necessity of generating GSH for metabolic 
response when astrocytes are treated with arsenic is clear. 
In a second set of conditions to establish the priority of GSH synthesis as opposed to 
redox cycling, astrocytes were treated with 0 μM and 10 μM NaAsO​2​ and separately with 0 
μM and 300 μM H​2​O​2​ with or without 6-aminonicotinamide (6AN, an inhibitor of the pentose 
phosphate pathway, PPP; see Figure 10, Appendix) (Figures 4C and D). Again, a similar 
comparison can be made. The PPP is in part responsible for replenishing nicotinamide 
adenine dinucleotide phosphate (NADPH), and when this pathway is inhibited, the ability of 
the cell to recycle oxidized glutathione, GSSG, back to its reduced state is impaired. Cell 
viability was not impacted under conditions of arsenic treatment, indicating that response 
depends little on the redox status of the cell but instead on an alternative metabolic pathway. 
These results suggest that indeed astrocytes rely on glutathione synthesis as opposed to 
recycling as the primary response to arsenic toxicity. 
 
 
B. Glutathione conjugation and export as a complex with arsenic 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. GSH forms a complex with arsenic compounds before export from the cell. Cells were treated with 0, 5, 10, and 20 μM NaAsO​2 
and 25 μM MK571 for 48h. As treatment concentrations increased a concentration-dependent decrease in viability was observed. ​*​ ​p < 0.05 
 
To examine the hypothesis of complex formation between arsenic and GSH for export 
from the cell, astrocytes were treated with concentrations of 0 μM, 5 μM, 10 μM, and 20 μM 
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of NaAsO​2​ with or without 25 μM MK571, an inhibitor of the MRP1 transport protein that is 
responsible for the export of GSH compounds from the cell (Figure 5). Following incubation 
and analysis (see Methods and Materials), results show a concentration-dependent decrease in 
cell viability compared to control conditions. This supports the hypothesis that GSH does 
form adducts with xenobiotic arsenic for export from the cell, which, when this action is 
inhibited, would cause an accumulation in the intracellular environment, decreasing cell 
survival. 
 
 
C. Mitochondrial glucose metabolism plays an important role 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Glucose metabolism carried out in mitochondria of astrocytes are important in xenobiotic defense. Cells were treated with 0, 5, and 
10 μM NaAsO​2​ and either 10 μM ​MPP​+​, ​250 ​μM of rotenone, or 50 μM PQ, or under control conditions, for 48h. At 10 μM NaAsO​2​, cells 
experienced decrease in survival (A). Under separate conditions cells were treated with 0, 10, and 20 μM NaAsO​2​ with or without UK5099 
for 48h. These cells also experienced a decrease at 10 μM NaAsO​2​. ​*​ ​p < 0.05 
 
Cells were treated with 0 μM, 5 μM, and 10 μM concentrations of NaAsO​2​ and 
concurrent treatment with one of three inhibitors of the electron transport train, used to block 
mitochondrial function: 10 μM of ​1-methyl-4-phenylpyridinium (MPP​+​), 250 ​μM of 
rotenone, or 50 μM of paraquat (PQ) (Figure 7A). At 10 μM, the capacity of astrocytes 
treated with all three compounds to respond adequately to arsenic was decreased 
significantly, while the control remained viable at this concentration. The electron transport 
train is linked to the TCA cycle by redox cycling of reducing agents FADH​2​ and NADH. By 
13 
preventing this system from supporting the TCA cycle, which generates glutamate via 
⍺-ketoglutarate for GSH synthesis, astrocytes are thus subject to arsenic toxicity. 
Cell cultures were also treated separately under the same NaAsO​2​ conditions but with 
or without 5 μM UK5099, an inhibitor of MPC1 transport protein, which imports pyruvate 
into the mitochondria for conversion into oxaloacetate and subsequent incorporation into the 
TCA cycle (Figure 7B). Here it is also evident by the decrease in cell survival at 10 μM of 
NaAsO​2​ that the metabolism of glucose carried out by the mitochondria is vital to 
maintaining cell viability in astrocytes in response to arsenic exposure. 
 
 
D. Mitochondrial conversion of pyruvate to oxaloacetate vs. acetyl-CoA in mitochondria 
 
 
 
 
 
 
 
 
 
 
Figure 8. Pyruvate conversion to oxaloacetate vs. acetyl-CoA. Cells were treated with 0, 10, and 20 μM NaAsO​2​ for 48h with or without 
DCA. There was a moderate reduction in cell viability at 10 μM NaAsO​2​ compared to the control. ​*​ ​p < 0.05 
 
Astrocyte cultures were treated with 0 μM, 5 μM, and 10 μM of NaAsO​2​, with or 
without 5 μM of dichloroacetate (DCA) (Figure 8), which inhibits the dephosphorylation of 
pyruvate dehydrogenase (PDH) via pyruvate dehydrogenase kinase (PDK). By preventing the 
dephosphorylation of PDH enzyme, more pyruvate is channeled into the production of 
acetyl-CoA for input into the TCA cycle. Alternatively, under normal circumstances, 
pyruvate may also be converted to oxaloacetate by pyruvate carboxylase (PC), another TCA 
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intermediate. The importance of this second pathway for pyruvate that has been taken up into 
the mitochondria was explored in addition to the central hypothesis given the fact that 
conversion to oxaloacetate does not occur in neurons, and may be key in the ability of 
astrocytes to serve in their defense when harmful xenobiotic compounds such as arsenic are 
introduced. It was speculated that causing the preferential conversion of pyruvate instead to 
acetyl-CoA may result in a decrease in cell survival when treated with arsenic.The results of 
this experiment indicate that at higher levels of arsenic, cell viability decreases slightly; 
however, cells were still able to maintain high levels of viability despite the diversion in 
mitochondrial glucose metabolism. Thus, without exploring pyruvate conversion to 
oxaloacetate further, it cannot be concluded that this contributes especially to astrocytes’ 
capacity to respond to arsenic exposure while maintaining viability.  
 
 
E. Free fatty acids support mitochondrial glucose metabolism 
 
 
 
 
 
 
 
 
 
Figure 9. Fatty acid oxidation supports astrocyte response to arsenic exposure. Cells were treated with 0, 10, and 20 μM NaAsO​2​  with or 
without 200 μM etomoxir. At 10 μM NaAsO​2​, cell viability was reduced significantly. ​*​ ​p < 0.05 
 
Acetyl-CoA is also provided by the cytoplasmic conversion of free fatty acids to acyl 
carnitine, which is then transported into the mitochondria and metabolized to acetyl-CoA. 
The importance of this source of acetyl-CoA was also explored as a potential metabolic 
mechanism through which astrocytes defend against xenobiotic threat. Astrocytes were 
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treated with concentrations of 0 μM, 5 μM, and 10 μM of NaAsO​2​, with or without 200 μM 
of etomoxir, which inhibits carnitine palmitoyltransferase (CPT1), an enzyme necessary in 
the conversion of fatty acid molecules  into acyl carnitine. . It was found that by inhibiting the 
contribution of this source of acetyl-CoA  to the TCA cycle, cell viability was reduced. This 
effect was not observed at the same level of arsenic treatment without CPT1 inhibition. This 
suggests that fatty acid oxidation, therefore, may be an important source of acetyl-CoA 
during detoxification of arsenic and other xenobiotics. 
 
Conclusions 
 
Astrocytes are vital for the defense of the central nervous system against the threat 
posed by environmental sources of toxicity. Arsenic is a ubiquitous environmental toxicant, 
and has been implicated in a number of adverse health effects resulting from chronic 
exposure. While some of these effects have been relatively well explored, effects on the 
central nervous system have been less so, particularly with reference to specific mechanisms 
of action and the metabolic processes involved. The series of experiments in this study in 
which astrocytes were exposed to inorganic arsenic and inhibitors of various metabolic 
pathways suspected to play a significant role in astrocyte response to such xenobiotics have 
attempted to elucidate these processes. As a result, support has been further given to the 
hypothesis that i) the upregulation of GSH biosynthesis is necessary, involving increased 
mitochondrial metabolic activity, as opposed to redox activity in the cytoplasm, and ii) that 
the resulting GSH is then directly complexed with the toxic xenobiotic compound for export 
from the cell. 
In addition, the importance of mitochondrial metabolism in astrocytes’ capacity to 
detoxify xenobiotics was investigated in terms of fatty acid metabolism, resulting in the 
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indication that fatty acid oxidation and the contribution of acetyl-CoA to the TCA cycle as a 
result of this pathway  is a potentially significant part of the response. Further exploration of 
these pathways is needed to confirm the degree to which fatty acid oxidation contributes, 
though these results are promising. 
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Appendix 
 
Diagram of experimental inhibitor compounds 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Rose, J., et al. (9) 
 
List of experimental compounds 
 
6AN ​(Alfa Aesar) - blocks pentose phosphate pathway, leading to depletion of NADPH and 
thus rendering GSH-GSSG redox recycling unavailable 
BSO​ - blocks glutathione biosynthesis by preventing incorporation of component amino 
acids 
DCA​ - inhibits PDK, allowing more pyruvate to be channeled into the production of 
acetyl-CoA 
Etomoxir​ - blocks CPT1, inhibiting fatty acid oxidation to TCA input acetyl-CoA in 
mitochondria 
MPP​+​ ​(Sigma-Aldrich) - blocks ETC at Complex I 
PQ (Acros Organics) - blocks ETC at Complex I 
Rot​ - blocks ETC at Complex I 
MK571​ - blocks MRP1 transport, preventing the export from the cell of the GSH-As 
complex 
UK5099​ - blocks MPC1 transport, inhibiting pyruvate transfer into the cell for incorporation 
into the TCA cycle by oxaloacetate 
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